AU6287894A - Inducible nitric oxide synthase and gene therefor - Google Patents

Inducible nitric oxide synthase and gene therefor

Info

Publication number
AU6287894A
AU6287894A AU62878/94A AU6287894A AU6287894A AU 6287894 A AU6287894 A AU 6287894A AU 62878/94 A AU62878/94 A AU 62878/94A AU 6287894 A AU6287894 A AU 6287894A AU 6287894 A AU6287894 A AU 6287894A
Authority
AU
Australia
Prior art keywords
nitric oxide
oxide synthase
inducible nitric
gene therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62878/94A
Inventor
Ian George Charles
Salvador Enrique Moncada
Richard Michael John Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU6287894A publication Critical patent/AU6287894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075—Nitric-oxide synthase (1.14.13.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU62878/94A 1993-03-26 1994-03-25 Inducible nitric oxide synthase and gene therefor Abandoned AU6287894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9306386 1993-03-26
GB939306386A GB9306386D0 (en) 1993-03-26 1993-03-26 Gene expression
PCT/GB1994/000621 WO1994023038A1 (en) 1993-03-26 1994-03-25 Inducible nitric oxide synthase and gene therefor

Publications (1)

Publication Number Publication Date
AU6287894A true AU6287894A (en) 1994-10-24

Family

ID=10732852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62878/94A Abandoned AU6287894A (en) 1993-03-26 1994-03-25 Inducible nitric oxide synthase and gene therefor

Country Status (3)

Country Link
AU (1) AU6287894A (en)
GB (1) GB9306386D0 (en)
WO (1) WO1994023038A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658565A (en) * 1994-06-24 1997-08-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Inducible nitric oxide synthase gene for treatment of disease
US5830461A (en) * 1992-11-25 1998-11-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods for promoting wound healing and treating transplant-associated vasculopathy
DE4411402A1 (en) * 1994-03-31 1995-10-05 Juergen Schrader DNA expression vectors for use in gene therapy treatment of vascular diseases
WO1996040785A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Monospecific antibodies and methods using them
EP0831714A1 (en) * 1995-06-07 1998-04-01 Merck & Co., Inc. Monospecific antibodies and methods using them
US5744340A (en) * 1995-06-09 1998-04-28 Schering Corporation Expression of human inducible nitric oxide synthase
US5908842A (en) * 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6531578B1 (en) * 1996-04-12 2003-03-11 Robert Webber Immunoassay method employing monoclonal antibody reactive to human iNOS
US7198904B1 (en) * 1996-04-12 2007-04-03 Robert Webber Immunoassay method employing monoclonal antibody reactive to human iNOS
ATE346917T1 (en) * 1996-09-20 2006-12-15 Daiichi Asubio Pharma Co Ltd METHOD FOR SCREENING COMPOUNDS THAT REGULATE THE EXPRESSION OF HUMAN INDUCIBLE NITROGEN OXIDE SYNTHASE
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
AU5081200A (en) * 1999-05-04 2000-11-17 Aventis Pharma S.A. Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
FR2793142A1 (en) * 1999-05-04 2000-11-10 Aventis Pharma Sa Antisense oligonucleotides of an inductible isoform of nitrogen monoxide synthase, used to treat cerebral ischemia
WO2001052902A1 (en) * 2000-01-24 2001-07-26 Isis Pharmaceuticals, Inc. Antisense modulation of inducible nitric oxide synthase expression
US20040053323A1 (en) * 2000-03-10 2004-03-18 Yoshinori Ishii Method of screening inducible nitric oxide synthase activation inhibitor

Also Published As

Publication number Publication date
WO1994023038A1 (en) 1994-10-13
GB9306386D0 (en) 1993-05-19

Similar Documents

Publication Publication Date Title
AU7819994A (en) Nitric oxide treatment
AU5749196A (en) N-nitroso-n-substituted hydroxylamines as nitric oxide donor s
AU1249295A (en) Chemically regulatable and anti-pathogenic dna sequences and uses thereof
AU6287894A (en) Inducible nitric oxide synthase and gene therefor
EP0648609A3 (en) Printer and methods
AU7369794A (en) Shaped lead structure and method
AU5997594A (en) Hi-density sintered alloy
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2861695A (en) Mn gene and protein
AU2575395A (en) Gene coding for glycosyltransferase and use thereof
AU5498198A (en) Beta-ketoacyl-acp-synthetase ii enzyme and gene encoding the same
AU5590394A (en) Transglutaminase gene
GB9708526D0 (en) Eukaryotic gene expression cassette and uses thereof
AU6528494A (en) Nitric oxide combination therapy
AU6149296A (en) Expression of human inducible nitric oxide synthase
AU5306396A (en) Osteoarthritis associated inducible nitric oxide synthase
AU4032793A (en) Nitric oxide sensor
AU7060594A (en) Cloning and uses of the genetic locus bcl-6
AU7731394A (en) Heater and tunnel arrangement
AU5455094A (en) Blast media containing mgo
AU1539399A (en) Inhibitors of nitric oxide synthase
AU6910296A (en) Overproduction of neuronal nitric oxide synthase
AU4330197A (en) Protein inhibitor of neuronal nitric oxide synthase
AU3761695A (en) Novel immunophilins and corresponding nucleic acids
AU6933694A (en) Refractory oxides